Series A · Biotech · Stockholm, Sweden · Founded 2021 · 50–90 employees
Cellcolabs is a Stockholm-based biotech startup revolutionizing stem cell production by manufacturing GMP-certified mesenchymal stem cells at industrial scale. Founded in 2021 based on 25+ years of research from the Karolinska Institute, the company aims to reduce stem cell costs by 90% by 2035, making advanced regenerative medicine treatments accessible globally. They recently raised €10.3 million bringing total funding to €31 million, and operate a GMP-certified facility serving hospitals, academic institutions, and private clients worldwide including professional athletes.